A new study found that “forever chemicals” could lead to kidney damage in young adults through dysregulations of their gut microbiome. View on euronews ...
The biomedical giant best known for its Cologuard at-home colon cancer screening test reported a loss of $38.2 million, or $0.21 per share, on revenue of $708.7 million.